Eli Lilly is a United States based pharmaceutical company and Boehringer Ingelheim is a German based pharmaceutical based company. The two companies have joined together to “forge the way to a massive expansion in diabetes research, prevention and treatment.”
The two companies plan to co-develop a new type 2 diabetic medication. In addition, the two companies combined have a nice portfolio of compounds that are in the clinical phases of develop they include Boehringer Ingelheim's two oral diabetes agents-linagliptin and BI1077 and Lilly's two basal insulin analogues-LY2605541 and LY2963016. The two companies plan to co-develop and co-commercialize Lilly's anti-TGF-beta monoclonal antibody into a diabetic medication.
Linagliptin is a dipeptidyl peptidase-4 inhibitor that is currently in the elemental stages of becoming an oral once a day tablet for type 2 diabetics. As of today there are very few once a day medications that last 24 hours. BI10773, a sodium-dependent glucose co-transporter-2 inhibitor that entered into phase 3 clinical trials last year. This medication once completely developed will block the reabsorption of glucose in the kidney. As of this time, there is no medication like this one available.
Both LY2605541 and LY2963016 are basal insulin which are about to enter into phase 3 clinical testing sometime during 2011. Both of these medications will help diabetics with kidney disease.
Together the two pharmaceutical giants have the money, the researchers and the equipment to develop this four and possibly a fifth medication that will give type 2 diabetics another choice of medication to help control their diabetes and even help with kidney disease caused by diabetes.
Source: http://www.medicalnewstoday.com/articles/213436.php
The information provided on InformationAboutDiabetes.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of InformationAboutDiabetes.com nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
The Diabetes Support Group at SupportGroups.com builds awareness and support for people with Diabetes. If you are a friend or parent of a person that has been diagnosed with Diabetes, or you have been diagnosed with Diabetes, you are not alone. Share experiences and get support in a confidential, caring environment.
Selected Support Groups
Follow and Share InformationAboutDiabetes.com